1st Circuit Affirms Preemption Of Zofran MDL Birth Defect Claims; No New Data
BOSTON — The First Circuit U.S. Court of Appeals on Jan. 9 affirmed summary judgment that all 482 cases in the Zofran birth defect multidistrict litigation are preempted because there was...To view the full article, register now.
Already a subscriber? Click here to view full article